Kymera Therapeutics, Inc. (KYMR)

Kymera Therapeutics Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	335.82	120.26	109.97	68.4	47.98	31
Short-Term Investments	329.63	368.49	264.92	338.77	394.44	265.2
Cash & Short-Term Investments	665.45	488.74	374.88	407.17	442.42	296.2
Cash Growth	30.49%	30.37%	-7.93%	-7.97%	49.36%	222.11%
Accounts Receivable	40	0.95	18.76	2.54	0.14	1.43
Receivables	40	0.95	18.76	2.54	0.14	1.43
Prepaid Expenses	22.88	20.58	11.67	9.71	8.72	4.7
Total Current Assets	728.33	510.27	405.32	419.42	451.27	302.34
Property, Plant & Equipment	94.62	97.86	101.08	22.24	21.31	20.69
Long-Term Investments	297.63	362.16	61.43	152.33	125.19	162.53
Other Long-Term Assets	10.5	7.74	7.93	9.15	8.14	1.62
Total Assets	1,131	978.04	575.76	603.13	605.91	487.18
Accounts Payable	5.78	5.99	7.08	4.34	4.01	4.37
Accrued Expenses	27.98	34.87	33.86	27.5	22.97	10.33
Current Portion of Leases	13.67	13.11	6.35	3.94	3.6	3.26
Current Unearned Revenue	40	13.58	37.88	35.26	61.74	92.55
Other Current Liabilities	0.12	0.22	0.52	0.3	0.23	0.11
Total Current Liabilities	87.54	67.77	85.69	71.34	92.54	110.62
Long-Term Leases	72.05	74.65	78.33	13.39	14.36	14.73
Long-Term Unearned Revenue	-	-	16.77	28	39.3	77.84
Other Long-Term Liabilities	-	-	-	0.25	0.07	0.1
Total Liabilities	159.59	142.42	180.79	112.98	146.27	203.29
Common Stock	0.01	0.01	0.01	0.01	0.01	0
Additional Paid-In Capital	1,868	1,592	926.27	878.88	689.28	412.78
Retained Earnings	-896.81	-754.61	-530.75	-383.79	-228.98	-128.77
Comprehensive Income & Other	0.28	-1.49	-0.55	-4.95	-0.66	-0.13
Total Common Equity	971.48	835.62	394.97	490.15	459.64	283.89
Shareholders' Equity	971.48	835.62	394.97	490.15	459.64	283.89
Total Liabilities & Equity	1,131	978.04	575.76	603.13	605.91	487.18
Total Debt	85.71	87.76	84.67	17.34	17.96	17.99
Net Cash (Debt)	877.36	763.14	351.64	542.16	549.64	440.74
Net Cash Growth	42.84%	117.02%	-35.14%	-1.36%	24.71%	522.83%
Net Cash Per Share	11.07	10.17	6.02	10.05	11.45	25.40
Filing Date Shares Outstanding	71.5	64.94	61.11	55.18	51.67	44.81
Total Common Shares Outstanding	70.56	64.89	55.59	55.04	51.5	44.48
Working Capital	640.79	442.5	319.63	348.07	358.73	191.72
Book Value Per Share	13.77	12.88	7.11	8.91	8.93	6.38
Tangible Book Value	971.48	835.62	394.97	490.15	459.64	283.89
Tangible Book Value Per Share	13.77	12.88	7.11	8.91	8.93	6.38
Machinery	15.79	14.75	6.74	5.8	4.02	2.59
Leasehold Improvements	44.17	44.01	7.8	7.8	7.74	7.6

Updated Aug 11, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q